Ex Parte Application by Shira Israella Klein-Bentsur to take discovery from Keryx Biopharmaceuticals Inc., Urogen Pharma Ltd., XTL Biophannaceuticals LLC, Nextgen Healthcare Information Systems LLC, E-QURE Corp., Stemline Therapeutics, Inc., Citibank N.A., HSBC Bank Plc, JPMorgan Chase & Co., TD Bank, N.A., Bank Leumi, Merrill Lynch, Wells Fargo, Oppenheimer & Co., UBS AG, Bank of New York Mellon, ABN AMRO Securities LLC, First Trade Union Bank, Bank of Ireland, Santander Bank, N.A., RBC Capital Markets, and Cornick, Garber & Sandler, LLP for use in legal proceedings in Israel involving Ron Bentsur, filed at the U. S. District Court for the Southern District of New York.
- Home
- Documents
- Type
- Court Filings
- Application
- Shira Israella Klein-Bentsur v. Keryx Biopharmaceuticals Inc. et al: Discovery Application
Application Civil Courts Discovery Documents Israel United States District Court for the Southern District of New York USANovember 28, 2018
Shira Israella Klein-Bentsur v. Keryx Biopharmaceuticals Inc. et al: Discovery Application
247
November 28, 2018
Shira Israella Klein-Bentsur
Xx Xx Xx
Keryx Biopharmaceuticals Inc., Urogen Pharma Ltd., XTL Biophannaceuticals LLC, Nextgen Healthcare Information Systems LLC, E-QURE Corp., Stemline Therapeutics, Inc., Citibank NA, HSBC Bank Plc, JPMorgan Chase & Co., TD Bank, NA, Bank Leumi, Merrill Lynch, Wells Fargo, Oppenheimer & Co., UBS AG, Bank of New York Mellon, ABN AMRO Securities LLC, First Trade Union Bank, Bank of Ireland, Santander Bank, NA, RBC Capital Markets, Cornick, Garber & Sandler, LLP
Topics
Israel USAKeywords
ABN Amro Banco Santander Bank Leumi Bank of Ireland Bank of New York Mellon